Double Certification: ISO 9001 and Cyber Essentials

ImmunoServ is delighted to announce that the company’s commitment to Quality Assurance and Cyber Security has been independently verified.

Read More

Omicron T cell test under development

Following the WHOs announcement about the new SARS-CoV-2 Omicron variant of concern (VoC) on 26 November 2021, the team here at ImmunoServ have started working on a T cell immune response test for this variant. This rapid development demonstrates the flexibility of our T cell testing platform and the dedication of our company to help in the ongoing fight against COVID-19.

Read More

Single blood test to measure T-cell and antibody response to SARS-CoV-2

ImmunoServ have been featured by Cardiff University for our work on a test to measure both the T-cell and antibody response to SARS-CoV-2 in a single blood sample.

Read More


We are delighted to announce the incorporation of ImmunoServ Ltd., a specialist contract research organisation in the immunology sector.

Read More

To stay updated on our latest news, please sign up to our newsletter.

Call or Email

Social Media

ImmunoServ launches Immuno-T™ Laboratory Test Kit

As part of our ongoing efforts to bring T cell testing to the masses, today ImmunoServ are proud to announce the launch of the COVID-19 Immuno-T™ Laboratory Test Kit. Having generated substantial impact during the COVID-19 pandemic with our contract T cell and antibody research services, the launch of the Immuno-T™ Laboratory Test Kit now enables standardised and scalable T cell testing to be performed in any laboratory throughout the world.

Read More

COVID-19 is back on the rise – is waning immunity really to blame?

The UK is currently in the midst of another wave of COVID-19, causing increases in hospitalisation rates [1]. Whilst the UK Health Security Agency do not believe the newly emerged and currently circulating SARS-CoV-2-Omicron subvariants to be any more dangerous than previous strains, experts have attributed the current wave to both increased indoor mixing and waning immunity [2]. But what data do we have to show that population immunity is in fact waning?

Read More

ImmunoServ awarded Welsh Government innovation funding

Funding to expand ImmunoServ’s portfolio of services for monitoring cellular immune responses.

Read More

Cardiff University Alumni Announce UK-India Strategic Partnership for Immunity Testing

1st March 2023 on St David’s Day, ImmunoServ from Cardiff, Wales, UK signed a Strategic Partnership with ImmunitasBio of Bangalore, India to formalise its support for each other in their shared purpose in providing expert immunology products and services across the world.

Read More

ImmunoServ wins Judges Award at MediWales Innovation Awards

On Thursday 8th December MediWales held their seventeenth annual MediWales Innovation Awards in Cardiff. It was a fabulous evening celebrating collaboration and innovation across the Welsh life science and health and social care sectors. ImmunoServ were thrilled to win the prestigious Industry Judges Award.

Read More

COVID-19 Immuno-T™ T cell test grabs the headlines

Last month ImmunoServ’s latest research in collaboration with Cardiff University was published in the prestigious Nature Communications journal. The research is the culmination of many years research, devotion and hard work. We are especially grateful to all the volunteers who contributed to this work, as well as those who funded the work including UKRI, InnovateUK, and the National Core Studies.

Read More

Immuno-T COVID T Cell Test Now Available to Buy

At ImmunoServ we are on a mission to bring T cell testing to the masses. The World’s first At-Home COVID-19 T cell test is now available to anyone in the United Kingdom. People who wish to test their own T cell immune response to COVID-19 using Immuno-TTM, can visit our Immuno-T website.

Read More

UKCA / IVD mark achieved for Immuno-T At Home Blood Collection Kit

ImmunoServ is proud to announce that it has obtained the UKCA (UK Conformity Assessed) mark for its Immuno-T At Home Blood Collection Kit.

Read More

Recruitment for At Home Immuno-T Validation Study Complete

In January 2022 ImmunoServ launched its trial of the Worlds first At-Home combined COVID-19 T cell and antibody test. Participants from across the UK were invited to sign up to the validation study. Within 10 weeks more than 300 participants have been recruited.

Read More

ImmunoServ Appoints New CEO

ImmunoServ is pleased to announce the appointment of Dr James Hindley as our new Chief Executive Officer. James brings a wealth of immunology and entrepreneurial experience in guiding biotech ventures; his proven leadership in the field is an excellent fit for ImmunoServ’s mission to provide expert immunology services to the world.

Read More

If you’re keen to work with us in achieving our vision please get in touch.